SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
April 15, 2024 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today...
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
March 04, 2024 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
February 26, 2024 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024
February 05, 2024 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application
January 30, 2024 08:30 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the...
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023
January 08, 2024 08:30 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023
November 14, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance
November 06, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023
November 01, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023
October 16, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...